Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€72.88
16.05.22
-
16.05.23
-2.92%
27.05.22

Probably not worthwhile Investment
Business model of the past or high risk
tinelchen 
16.05.22 0%
sell
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€488.40
15.06.21
-
15.06.22
-27.06%
21.05.22

EBIT growth >5% per year expected
Very low/no dividend yield expected
GraveDigger 
15.06.21 50%
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year
melinda 
01.05.21 50%
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
melinda 
07.06.21 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€66.35
25.03.22
-
25.04.22
6.07%
26.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
25.03.22 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
04.04.22 80%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
23.03.22 90%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€470.00
13.10.21
-
13.10.22
24.89%
13.03.22

Kilianhammernick 
13.10.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€37.80
23.09.21
-
23.09.22
22.31%
13.03.22

Kilianhammernick 
23.09.21 50%
sell
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€160.00
09.09.21
-
09.09.22
-2.97%
10.03.22

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Vortex 
09.09.21 50%
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
melinda 
09.03.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.21
08.07.21
€55.00
08.07.22
29.12%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
08.07.21 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€192.48
12.01.22
€240.00
12.01.23
-0.52%
16.02.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
sell
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
24.01.22 60%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
13.12.21 60%
sell
Illumina Inc.

Start price
Target price
Perf. (%)
€364.50
11.01.22
-
11.01.23
-8.29%
21.01.22

Probably not worthwhile Investment
tinelchen 
11.01.22 0%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Troubadour 
27.02.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
19.01.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
09.11.21 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
gerihouse 
25.01.21 90%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
stepdown 
31.12.20 80%
sell
Johnson & Johnson

Start price
Target price
Perf. (%)
€147.94
22.12.21
-
22.12.25
1.31%
28.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilbert 
22.12.21 50%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%